Radiotherapy plus anti-PD1 versus radiotherapy for hepatic toxicity in patients with hepatocellular carcinoma

PURPOSE: In this study, we aimed to compare the radiation-induced hepatic toxicity (RIHT) outcomes of radiotherapy (RT) plus antibodies against programmed cell death protein 1 (anti-PD1) versus RT alone in patients with hepatocellular carcinoma (HCC), evaluate prognostic factors of non-classic radia...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Rui-Jun, Zhou, Hong-Mei, Lu, Hai-Yan, Yu, Hong-Ping, Tang, Wei-Zhong, Qiu, Mo-Qin, Yan, Liu-Ying, Long, Mei-Ying, Su, Ting-Shi, Xiang, Bang-De, He, Mei-Ling, Wang, Xiao-Ting, Liang, Shi-Xiong, Li, Jian-Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403970/
https://www.ncbi.nlm.nih.gov/pubmed/37542246
http://dx.doi.org/10.1186/s13014-023-02309-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403970/
https://www.ncbi.nlm.nih.gov/pubmed/37542246
http://dx.doi.org/10.1186/s13014-023-02309-1

Ejemplares similares